UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 256

Sortiert nach

Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn's disease

Expert review of gastroenterology & hepatology, 2023-06, Vol.17 (6), p.575-587

2023

Link zum Volltext

Verfügbarkeit prüfen

EE361 From Biobank Sample to Breast Cancer Prevention—Cost-Effectiveness Analysis of Returning Genomic Data to Sample Donors

Value in health, 2023-12, Vol.26 (12), p.S120

2023

Link zum Volltext

Verfügbarkeit prüfen

P113 Protein fingerprint biomarkers of collagen remodeling can evaluate fibrogenesis in an in vitro colonic scar-in-a-jar model

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i277-i280

2023

Link zum Volltext

Verfügbarkeit prüfen

EE345 Lifetime Cost-Effectiveness of Hereditary Breast and Ovarian Cancer Prevention Based on FinnGen and Biobank Data, Data Returning Process, and Prophylaxis

Value in health, 2024-06, Vol.27 (6), p.S120-S121

2024

Link zum Volltext

Verfügbarkeit prüfen

P308 CPa9-HNE: A NEUTROPHIL-DERIVED FRAGMENT OF CALPROTECTIN MEASURED IN SERUM CAN MONITOR ENDOSCOPIC AND CLINICAL DISEASE ACTIVITY IN ULCERATIVE COLITIS

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i687-i688

2024

Link zum Volltext

Verfügbarkeit prüfen

P136 Blood-based biomarkers of type III collagen remodeling as surrogate markers of endoscopic disease activity in patients with Ulcerative Colitis

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i431-i432

2024

Link zum Volltext

Verfügbarkeit prüfen

P197 A biomarker of early mucosal destruction: Neutrophil-mediated type IV collagen degradation is elevated in patients with Crohn’s Disease and Ulcerative Colitis

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i349-i351

2023

Link zum Volltext

Verfügbarkeit prüfen

P384 Serum biomarkers of proteolytic type III and type IV collagen remodeling differentiate patients with Inflammatory Bowel Disease according to infliximab treatment response or non-response

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i806-i808

2024

Link zum Volltext

Verfügbarkeit prüfen

P336 Exploring Extracellular Matrix Markers in Ulcerative Colitis: Degradation and Formation Insights

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i728-i729

2024

Link zum Volltext

Verfügbarkeit prüfen

P318 Protein FingerPrint assays reflecting neutrophil activity, mucosal damage, and tissue fibrosis are surrogate biomarkers for mucosal healing in pediatric Crohn’s disease

Journal of Crohn's and colitis, 2023-01, Vol.17 (Supplement_1), p.i458-i459

2023

Link zum Volltext

Verfügbarkeit prüfen

P242 Immune-cell specific biomarker of early intestinal inflammation: Neutrophil elastase degraded fragment of type III collagen is elevated in patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i586-i588

2024

Link zum Volltext

Verfügbarkeit prüfen

P165 Non-invasive biomarkers of type III collagen cross-linking reflects fibrolysis in patient with luminal CROHN’S DISEASE

Journal of Crohn's and colitis, 2021-05, Vol.15 (Supplement_1), p.S241-S242

2021

Link zum Volltext

Verfügbarkeit prüfen

Stable serum levels of relaxin throughout the menstrual cycle: a preliminary comparison of women with premenstrual dysphoria and controls

Archives of women's mental health, 2007-08, Vol.10 (4), p.147-153

2007

Link zum Volltext

Verfügbarkeit prüfen

P509 Biomarkers of neutrophil activity and extracellular matrix turnover predict long-term response to vedolizumab in patients with Crohn’s disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i468-i469

2022

Link zum Volltext

Verfügbarkeit prüfen

P101 Biomarkers of elastin degradation are associated with clinical and biochemically active disease in Crohn’s disease

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S185-S186

2020

Link zum Volltext

Verfügbarkeit prüfen

P087 Biomarkers of elastin degradation differentiate between clinically inactive and active disease in ulcerative colitis patients

Journal of Crohn's and colitis, 2020-01, Vol.14 (Supplement_1), p.S178-S179

2020

Link zum Volltext

Verfügbarkeit prüfen

P611 Serological biomarkers of type VI and XXII collagen formation predict and monitor infliximab treatment response in patients with Crohn’s disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i541-i541

2022

Link zum Volltext

Verfügbarkeit prüfen

P127 Type I collagen degradation fragments (C1M) and human neutrophil elastase-derived fragments of calprotectin (CPa9-HNE) reflect biochemical and endoscopic disease activity in patients with Inflammatory Bowel Disease

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i214-i215

2022

Link zum Volltext

Verfügbarkeit prüfen

P204 Endotrophin (PRO-C6) is associated with MRE confirmed intestinal strictures and Protein FingerPrint biomarkers of collagen degradation is associated with ulcerations in paediatric Crohn’s disease patients – results from the ImageKids study

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i264-i265

2022

Link zum Volltext

Verfügbarkeit prüfen

Chapter 18 - Type XVIII collagen

Biochemistry of Collagens, Laminins and Elastin, 2024, p.161-173

Third Edition, 2024

Link zum Volltext

Verfügbarkeit prüfen

Chapter 44 - Collagen remodeling in inflammatory bowel disease

Biochemistry of Collagens, Laminins and Elastin, 2024, p.483-494

Third Edition, 2024

Link zum Volltext

Verfügbarkeit prüfen

Type XVIII collagen

Biochemistry of Collagens, Laminins and Elastin, 2023

Karsdal, Morten

2023

Link zum Volltext

Verfügbarkeit prüfen

Chapter 3 - Type III collagen

Biochemistry of Collagens, Laminins and Elastin, 2024, p.23-35

Third Edition, 2024

Link zum Volltext

Verfügbarkeit prüfen

Collagen remodeling in inflammatory bowel disease

Biochemistry of Collagens, Laminins and Elastin, 2023

Karsdal, Morten

2023

Link zum Volltext

Verfügbarkeit prüfen

Type III collagen

Biochemistry of Collagens, Laminins and Elastin, 2023

Karsdal, Morten

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 256

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(228)
Mit Volltextzugriff
(218)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(161)
Life Sciences & Biomedicine
(101)
Humans
(77)
Physical Sciences
(65)
Male
(49)
Female
(45)
Biological And Medical Sciences
(43)
Chemistry
(39)
Technology
(37)
Middle Aged
(33)
Medical Sciences
(32)
Medicin Och Hälsovetenskap
(32)
Food Science & Technology
(24)
Materials Science
(24)
Aged
(23)
Nutrition & Dietetics
(23)
Adult
(22)
Physics
(22)
Chemistry, Applied
(21)
Materials Science, Multidisciplinary
(21)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Novel fibro-inflammatory biomarkers associated with disease activity in patients with Crohn's disease

EE361 From Biobank Sample to Breast Cancer Prevention—Cost-Effectiveness Analysis of Returning Genomic Data to Sample Donors

P113 Protein fingerprint biomarkers of collagen remodeling can evaluate fibrogenesis in an in vitro colonic scar-in-a-jar model

EE345 Lifetime Cost-Effectiveness of Hereditary Breast and Ovarian Cancer Prevention Based on FinnGen and Biobank Data, Data Returning Process, and Prophylaxis

P308 CPa9-HNE: A NEUTROPHIL-DERIVED FRAGMENT OF CALPROTECTIN MEASURED IN SERUM CAN MONITOR ENDOSCOPIC AND CLINICAL DISEASE ACTIVITY IN ULCERATIVE COLITIS

P136 Blood-based biomarkers of type III collagen remodeling as surrogate markers of endoscopic disease activity in patients with Ulcerative Colitis

P197 A biomarker of early mucosal destruction: Neutrophil-mediated type IV collagen degradation is elevated in patients with Crohn’s Disease and Ulcerative Colitis

P384 Serum biomarkers of proteolytic type III and type IV collagen remodeling differentiate patients with Inflammatory Bowel Disease according to infliximab treatment response or non-response

P336 Exploring Extracellular Matrix Markers in Ulcerative Colitis: Degradation and Formation Insights

P318 Protein FingerPrint assays reflecting neutrophil activity, mucosal damage, and tissue fibrosis are surrogate biomarkers for mucosal healing in pediatric Crohn’s disease

P242 Immune-cell specific biomarker of early intestinal inflammation: Neutrophil elastase degraded fragment of type III collagen is elevated in patients with Inflammatory Bowel Disease

P165 Non-invasive biomarkers of type III collagen cross-linking reflects fibrolysis in patient with luminal CROHN’S DISEASE

Stable serum levels of relaxin throughout the menstrual cycle: a preliminary comparison of women with premenstrual dysphoria and controls

P509 Biomarkers of neutrophil activity and extracellular matrix turnover predict long-term response to vedolizumab in patients with Crohn’s disease

P101 Biomarkers of elastin degradation are associated with clinical and biochemically active disease in Crohn’s disease

P087 Biomarkers of elastin degradation differentiate between clinically inactive and active disease in ulcerative colitis patients

P611 Serological biomarkers of type VI and XXII collagen formation predict and monitor infliximab treatment response in patients with Crohn’s disease

P127 Type I collagen degradation fragments (C1M) and human neutrophil elastase-derived fragments of calprotectin (CPa9-HNE) reflect biochemical and endoscopic disease activity in patients with Inflammatory Bowel Disease

P204 Endotrophin (PRO-C6) is associated with MRE confirmed intestinal strictures and Protein FingerPrint biomarkers of collagen degradation is associated with ulcerations in paediatric Crohn’s disease patients – results from the ImageKids study

Chapter 18 - Type XVIII collagen

Chapter 44 - Collagen remodeling in inflammatory bowel disease

Type XVIII collagen

Chapter 3 - Type III collagen

Collagen remodeling in inflammatory bowel disease

Type III collagen

Suchergebnisse filtern